Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 6Sanofi
02 3Dr. Reddy's Laboratories
03 1Breckenridge Pharmaceutical
04 1NanoAlvand
05 1Ever Pharma
06 6Accord healthcare
07 1Accure Labs
08 1Actavis Inc
09 1Adcock Ingram
10 1Apotex Inc
11 1BPI Labs
12 1CinnaGen Co
13 1DR REDDY'S LABORATORIES LTD
14 1Fresenius Kabi USA
15 1Hetero Drugs
16 2InterPharma
17 1Jodas Expoim Pvt. Ltd
18 2Juno Pharmaceuticals Pty Ltd
19 1Kremedine Health
20 1Labatec Pharm
21 1ORIFARM GROUP AS
22 1Panacea Biotec Limited
23 2Reach Pharmaceuticals
24 1SEACROSS PHARMACEUTICALS
25 6Sandoz B2B
26 1Sichuan Xieli Pharmaceutical
27 1Spirig Healthcare
28 1Teva Pharmaceutical Industries
29 4TherDose Pharma
30 2Viatris
01 1CONCENTRATE AND SOLVENT FOR
02 1Cabazitaxel 60Mg 1 Unit Parenteral Use
03 2Concentrate and liquid to the infusion fluid, resolution
04 1Concentrate for Solution for Infusion
05 1Concentrate for infusion solution, solution
06 3INF
07 1INJ
08 1INJECTABLE;INJECTION
09 2INJECTION
10 5Inf Conc
11 1Inf Konz
12 1Inf L?s
13 1Injectable
14 9Injection
15 4SOLUTION
16 10SOLUTION;INTRAVENOUS
17 1UNKNOWN
18 1Vial
19 8Blank
01 5DISCN
02 7Generic
03 1Lead Market Dossiers- Approved in both US & EU
04 1Lead Market Dossiers- Filed
05 1Originator
06 3Prescription
07 3RX
08 33Blank
01 11CABAZITAXEL
02 3CABAZITAXEL FOR INJECTION
03 1CABAZITHER
04 3Cabazitaxel Accord
05 1Cabazitaxel Adco
06 2Cabazitaxel Ever Pharma
07 2Cabazitaxel Juno
08 1Cabazitaxel Labatec
09 2Cabazitaxel Sandoz
10 1Cabazitaxel Spirig HC
11 1Cabazitaxel Viatris
12 1Cabazitaxel-Teva
13 1Cabitas
14 2Cabotax
15 1Cabxel 60mg/1.5ml IV
16 3DASATED
17 1JEVTANA
18 1JEVTANA KIT
19 5Jevtana
20 2MSN Cabazitaxel
21 9Blank
01 8Australia
02 1Austria
03 3Canada
04 1China
05 10India
06 2Iran
07 1Italy
08 3Norway
09 4South Africa
10 1Sweden
11 7Switzerland
12 12USA
13 1United Kingdom
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : RX
Registration Country : USA
Brand Name : JEVTANA KIT
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/1.5ML (40MG/ML)
Packaging :
Approval Date : 2010-06-17
Application Number : 201023
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/1.5ML (40MG/ML)
Packaging :
Approval Date : 2023-02-10
Application Number : 207718
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/1.5ML (40MG/ML)
Packaging :
Approval Date : 2022-06-23
Application Number : 207619
Regulatory Info : DISCN
Registration Country : USA
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cabotax
Dosage Form : Vial
Dosage Strength : 60MG/1.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.
Regulatory Info :
Registration Country : Austria
Brand Name :
Dosage Form : Concentrate for Solution for Infusion
Dosage Strength : 10MG/1ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Austria
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Sweden
Brand Name : JEVTANA
Dosage Form : CONCENTRATE AND SOLVENT FOR
Dosage Strength : 60 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Jevtana
Dosage Form : Cabazitaxel 60Mg 1 Unit Parenteral Use
Dosage Strength : 1 vial EV 60 mg 1.5 ml + 1 vial solv 4.5 ml
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Norway
Brand Name : Jevtana
Dosage Form : Concentrate and liquid to the infusion fluid, resolution
Dosage Strength : 60 mg
Packaging : Hood glass
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Norway
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Switzerland
Brand Name : Jevtana
Dosage Form : Inf Konz
Dosage Strength : 60mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Jevtana
Dosage Form : INF
Dosage Strength : 60mg/6ml
Packaging : 6X1mg/6ml
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Brand Name :
Dosage Form : Injection
Dosage Strength : 60MG/1.5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Approved in both US & EU
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/1.5ML (40MG/ML)
Packaging :
Approval Date : 2022-10-26
Application Number : 207693
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/3ML (20MG/ML)
Packaging :
Approval Date : 2021-12-29
Application Number : 207949
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/6ML (10MG/ML)
Packaging :
Approval Date : 2024-03-14
Application Number : 207970
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/1.5ML (40MG/ML)
Packaging :
Approval Date : 2023-02-10
Application Number : 207736
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : UNKNOWN
Dosage Strength : UNKNOWN
Packaging :
Approval Date :
Application Number : 207735
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : INJECTABLE;INJECTION
Dosage Strength : 20MG/ML
Packaging :
Approval Date :
Application Number : 207937
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 45MG/4.5ML (10MG/ML)
Packaging :
Approval Date :
Application Number : 208715
Regulatory Info :
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CABAZITAXEL
Dosage Form : SOLUTION;INTRAVENOUS
Dosage Strength : 60MG/1.5ML (40MG/ML)
Packaging :
Approval Date : 2023-07-05
Application Number : 207381
Regulatory Info : DISCN
Registration Country : USA
